Literature DB >> 25207592

Deterioration of Physical Activity Level and Metabolic Risk Factors After Early-Stage Breast Cancer Diagnosis.

Aude-Marie Foucaut1, Sophie E Berthouze, Marina Touillaud, Magali Morelle, Valérie Bourne-Branchu, Anne-Sophie Kempf-Lépine, Julien Carretier, David Pérol, Olivier Trédan, Patrick Bachmann, Béatrice Fervers.   

Abstract

BACKGROUND: In breast cancer patients, a lack of physical activity (PA) is 1 causative factor of weight gain during adjuvant treatment. It may increase the risk of treatment adverse effects, comorbidities, and deleterious long-term outcomes.
OBJECTIVE: We aimed to describe the evolution of PA level and sedentary behavior in breast cancer patients between diagnosis and adjuvant chemotherapy onset following surgery and identify predictive factors associated with these changes early after breast cancer diagnosis.
METHODS: Baseline data of 60 patients enrolled in a pilot randomized controlled trial of PA are presented. PA levels were estimated at adjuvant chemotherapy onset after surgery and retrospectively for the period at diagnosis. Height, weight, waist circumference, and bioelectrical impedance were measured at chemotherapy onset. Linear regression analysis evaluated factors associated with relative changes of PA level and sedentary behavior.
RESULTS: Moderate PA decreased and sedentary behavior increased between diagnosis and chemotherapy onset. A grade III breast cancer was associated with a greater decrease in PA level. Conversely, keeping a professional occupation and adherence to nutritional guidelines were associated with maintained PA level. The majority (88%) of patients had excessive adiposity at chemotherapy onset.
CONCLUSIONS: There was a significant deterioration of PA level between diagnosis and chemotherapy onset, and deleterious adiposity was present in most patients. IMPLICATIONS FOR PRACTICE: This study further emphasizes the need to motivate breast cancer patients toward engaging in a healthy lifestyle early after diagnosis and adhering to PA programs, which should be included in their clinical management.

Entities:  

Mesh:

Year:  2015        PMID: 25207592     DOI: 10.1097/NCC.0000000000000187

Source DB:  PubMed          Journal:  Cancer Nurs        ISSN: 0162-220X            Impact factor:   2.592


  6 in total

1.  Insulin resistance and weight gain in women treated for early stage breast cancer.

Authors:  Grace Makari-Judson; Richard Viskochil; Deborah Katz; Ruth Barham; Wilson C Mertens
Journal:  Breast Cancer Res Treat       Date:  2022-05-21       Impact factor: 4.872

2.  Variations of physical activity and sedentary behavior between before and after cancer diagnosis: Results from the prospective population-based NutriNet-Santé cohort.

Authors:  Philippine Fassier; Laurent Zelek; Valentin Partula; Bernard Srour; Patrick Bachmann; Marina Touillaud; Nathalie Druesne-Pecollo; Pilar Galan; Patrice Cohen; Hélène Hoarau; Paule Latino-Martel; Mehdi Menai; Jean-Michel Oppert; Serge Hercberg; Mélanie Deschasaux; Mathilde Touvier
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

3.  Feasibility and Health Benefits of an Individualized Physical Activity Intervention in Women With Metastatic Breast Cancer: Intervention Study.

Authors:  Lidia Delrieu; Vincent Pialoux; Olivia Pérol; Magali Morelle; Agnès Martin; Christine Friedenreich; Olivia Febvey-Combes; David Pérol; Elodie Belladame; Michel Clémençon; Eva Roitmann; Armelle Dufresne; Thomas Bachelot; Pierre Etienne Heudel; Marina Touillaud; Olivier Trédan; Béatrice Fervers
Journal:  JMIR Mhealth Uhealth       Date:  2020-01-28       Impact factor: 4.773

4.  Adapted Physical Activity for Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Trastuzumab Against HER2 (APACAN2): A Protocol for a Feasibility Study.

Authors:  Angeline Ginzac; Maureen Bernadach; Ioana Molnar; Martine Duclos; Emilie Thivat; Xavier Durando
Journal:  Front Oncol       Date:  2021-12-13       Impact factor: 6.244

5.  Connected device and therapeutic patient education to promote physical activity among women with localised breast cancer (DISCO trial): protocol for a multicentre 2×2 factorial randomised controlled trial.

Authors:  Marina Touillaud; Baptiste Fournier; Olivia Pérol; Lidia Delrieu; Aurélia Maire; Elodie Belladame; David Pérol; Lionel Perrier; Marie Preau; Tanguy Leroy; Jean-Baptiste Fassier; Florie Fillol; Sébastien Pascal; Thierry Durand; Béatrice Fervers
Journal:  BMJ Open       Date:  2021-09-13       Impact factor: 2.692

6.  Digital phenotyping in young breast cancer patients treated with neoadjuvant chemotherapy (the NeoFit Trial): protocol for a national, multicenter single-arm trial.

Authors:  Lidia Delrieu; Anne-Sophie Hamy; Florence Coussy; Amyn Kassara; Bernard Asselain; Juliana Antero; Paul De Villèle; Elise Dumas; Nicolas Forstmann; Julien Guérin; Judicael Hotton; Christelle Jouannaud; Maud Milder; Armand Leopold; Adrien Sedeaud; Pauline Soibinet; Jean-François Toussaint; Vincent Vercamer; Enora Laas; Fabien Reyal
Journal:  BMC Cancer       Date:  2022-05-04       Impact factor: 4.638

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.